We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHI icon
1901
National Health Investors
NHI
$3.44B
$97K ﹤0.01%
1,878
+922
+96% +$50.3K
ONON icon
1902
On Holding
ONON
$10.3B
$97K ﹤0.01%
3,111
+2,927
+1,591% +$66.3K
TW icon
1903
Tradeweb Markets
TW
$22B
$97K ﹤0.01%
1,236
-53
-4% -$3.84K
VIV icon
1904
Telefônica Brasil
VIV
$18.6B
$97K ﹤0.01%
+11,458
New +$86.1K
VMEO
1905
DELISTED
Vimeo
VMEO
$97K ﹤0.01%
25,462
+24,251
+2,003% +$95.1K
AB icon
1906
AllianceBernstein
AB
$3.45B
$96K ﹤0.01%
+2,628
New +$99K
CMPS
1907
Compass Pathways
CMPS
$1.85B
$96K ﹤0.01%
9,691
+4,515
+87% +$41.6K
CVCO icon
1908
Cavco Industries
CVCO
$4.57B
$96K ﹤0.01%
301
+288
+2,215% +$79.7K
HGV icon
1909
Hilton Grand Vacations
HGV
$3.34B
$96K ﹤0.01%
2,151
+1,273
+145% +$57.7K
IIIN icon
1910
Insteel Industries
IIIN
$633M
$96K ﹤0.01%
3,441
+3,232
+1,546% +$93.9K
IRT icon
1911
Independence Realty Trust
IRT
$3.93B
$96K ﹤0.01%
6,005
-117
-2% -$2.05K
MRSN
1912
DELISTED
Mersana Therapeutics
MRSN
$96K ﹤0.01%
938
-530
-36% -$74.4K
MVST icon
1913
Microvast
MVST
$332M
$96K ﹤0.01%
77,153
+74,264
+2,571% +$108K
NTST
1914
NETSTREIT Corp
NTST
$2.02B
$96K ﹤0.01%
5,268
+5,020
+2,024% +$96.9K
ONEV icon
1915
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$305M
$96K ﹤0.01%
913
-126
-12% -$13.4K
UPWK icon
1916
Upwork
UPWK
$1.04B
$96K ﹤0.01%
8,528
+2,190
+35% +$26.1K
WDS icon
1917
Woodside Energy
WDS
$44.3B
$96K ﹤0.01%
4,291
+3,874
+929% +$93.1K
ABCM
1918
DELISTED
Abcam PLC
ABCM
$96K ﹤0.01%
7,155
+125
+2% +$1.87K
CHRS icon
1919
Coherus Oncology
CHRS
$187M
$95K ﹤0.01%
13,805
+9,321
+208% +$72.3K
MRCY icon
1920
Mercury Systems
MRCY
$6.55B
$95K ﹤0.01%
1,850
-72
-4% -$3.64K
NIO icon
1921
NIO
NIO
$11.6B
$95K ﹤0.01%
9,006
+8,983
+39,057% +$91.8K
PAHC icon
1922
Phibro Animal Health
PAHC
$1.38B
$95K ﹤0.01%
6,229
+3,730
+149% +$57K
ROG icon
1923
Rogers Corp
ROG
$2.41B
$95K ﹤0.01%
581
+474
+443% +$68.4K
SCHF icon
1924
Schwab International Equity ETF
SCHF
$68.5B
$95K ﹤0.01%
5,480
-33,340
-86% -$571K
VOYA icon
1925
Voya Financial
VOYA
$8.9B
$95K ﹤0.01%
1,329
-450
-25% -$31.5K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.